PKCδ activated by c-MET enhances infiltration of human glioblastoma cells through NOTCH2 signaling
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hwang, Eunji | - |
dc.contributor.author | Yoo, Ki-Chun | - |
dc.contributor.author | Kang, Seok-Gu | - |
dc.contributor.author | Kim, Rae-Kwon | - |
dc.contributor.author | Cui, Yan-Hong | - |
dc.contributor.author | Lee, Hae-June | - |
dc.contributor.author | Kim, Min-Jung | - |
dc.contributor.author | Lee, Jae-Seong | - |
dc.contributor.author | Kim, In-Gyu | - |
dc.contributor.author | Suh, Yongjoon | - |
dc.contributor.author | Lee, Su-Jae | - |
dc.date.accessioned | 2021-08-02T17:51:14Z | - |
dc.date.available | 2021-08-02T17:51:14Z | - |
dc.date.created | 2021-05-12 | - |
dc.date.issued | 2016-01 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/24716 | - |
dc.description.abstract | Poor prognosis of glioblastoma (GBM) is attributable to the propensity of tumor cells to infiltrate into the brain parenchyma. Protein kinase C (PKC) isozymes are highly expressed or aberrantly activated in GBM. However, how this signaling node translates to GBM cell invasiveness remains unknown. Here, we report that among PKC isoforms, PKC delta is strongly associated with infiltration of GBM cells. Notably, PKC delta enhanced Tyr418 phosphorylation of the non-receptor tyrosine kinase SRC, which in turn activated STAT3 and subsequent NOTCH2 signaling, ultimately leading to GBM cell invasiveness. Furthermore, we showed that PKC delta was aberrantly activated in GBM cells by c-MET, a receptor tyrosine kinase hyperactivated in GBM. In agreement, inhibition either component in the c-MET/PKC delta/SRC/STAT3 signaling axis effectively blocked the NOTCH2 signaling and invasiveness of GBM cells. Taken together, our findings shed a light on the signaling mechanisms behind the constitutive activation of PKC delta signaling in GBM. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | IMPACT JOURNALS LLC | - |
dc.title | PKCδ activated by c-MET enhances infiltration of human glioblastoma cells through NOTCH2 signaling | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Su-Jae | - |
dc.identifier.doi | 10.18632/oncotarget.6640 | - |
dc.identifier.scopusid | 2-s2.0-84958012537 | - |
dc.identifier.wosid | 000369952400093 | - |
dc.identifier.bibliographicCitation | ONCOTARGET, v.7, no.4, pp.4890 - 4902 | - |
dc.relation.isPartOf | ONCOTARGET | - |
dc.citation.title | ONCOTARGET | - |
dc.citation.volume | 7 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 4890 | - |
dc.citation.endPage | 4902 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalResearchArea | Cell Biology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.relation.journalWebOfScienceCategory | Cell Biology | - |
dc.subject.keywordPlus | PROTEIN-KINASE-C | - |
dc.subject.keywordPlus | CANCER STEM-CELLS | - |
dc.subject.keywordPlus | IN-VIVO | - |
dc.subject.keywordPlus | TARGET | - |
dc.subject.keywordPlus | SURVIVAL | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordPlus | PROLIFERATION | - |
dc.subject.keywordPlus | INHIBITION | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | RATIONALE | - |
dc.subject.keywordAuthor | PKCd | - |
dc.subject.keywordAuthor | infiltration | - |
dc.subject.keywordAuthor | glioblastoma | - |
dc.subject.keywordAuthor | NOTCH2 | - |
dc.subject.keywordAuthor | c-MET | - |
dc.identifier.url | https://www.oncotarget.com/article/6640/text/ | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.